Pancreatic Cancer Research

ResearcherHouston MethodistActive in the last 2 years

Hong Zhao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8991-7824; OpenAlex author ID A5101580545. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. KRAS Inhibition Activates an Actionable CD24 "Do Not Eat Me" Signal in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-25-2024↗
  2. β‑elemene inhibits the generation of peritoneum effusion in pancreatic cancer via suppression of the HIF1A‑VEGFA pathway based on network pharmacology. Last author DOI 10.3892/or.2019.7360↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrea Viale · 1 shared paper, 2025 · strength 0.17
  2. Dan Zhao · 1 shared paper, 2025 · strength 0.17
  3. Abdelrahman M.G. Yousef · 1 shared paper, 2025 · strength 0.17
  4. Ching-Fei Li · 1 shared paper, 2025 · strength 0.17
  5. Yongkun Wei · 1 shared paper, 2025 · strength 0.17
  6. Huamin Wang · 1 shared paper, 2025 · strength 0.17
  7. Timothy Paul Heffernan · 1 shared paper, 2025 · strength 0.17
  8. Jun Yao · 1 shared paper, 2025 · strength 0.17
  9. Haoqiang Ying · 1 shared paper, 2025 · strength 0.17
  10. Ronald Anthony Depinho · 1 shared paper, 2025 · strength 0.17
  11. Wantong Yao · 1 shared paper, 2025 · strength 0.17
  12. Junqiu Zhu · 1 shared paper, 2019 · strength 0.11
  13. Bo Li · 1 shared paper, 2019 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.